Cargando…
A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management
Delirium superimposed on dementia (DSD) occurs when patients with pre-existing dementia develop delirium. This complication causes patients to become impaired, posing safety concerns for both hospital staff and patients. Furthermore, there is an increased risk of worsening functional disability and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163832/ https://www.ncbi.nlm.nih.gov/pubmed/37159618 http://dx.doi.org/10.7759/cureus.38627 |
_version_ | 1785037964646023168 |
---|---|
author | Jahangir, Saira Allala, Manoj Khan, Armughan S Muyolema Arce, Veronica E Patel, Anandkumar Soni, Karsh Sharafshah, Alireza |
author_facet | Jahangir, Saira Allala, Manoj Khan, Armughan S Muyolema Arce, Veronica E Patel, Anandkumar Soni, Karsh Sharafshah, Alireza |
author_sort | Jahangir, Saira |
collection | PubMed |
description | Delirium superimposed on dementia (DSD) occurs when patients with pre-existing dementia develop delirium. This complication causes patients to become impaired, posing safety concerns for both hospital staff and patients. Furthermore, there is an increased risk of worsening functional disability and death. Despite medical advances, DSD provides both diagnostic and therapeutic challenges to providers. Identifying at-risk patients and providing personalized medicine and patient care can decrease disease burden in a time-efficient manner. This review delves into bioinformatics-based studies of DSD in order to design and implement a personalized medicine-based approach. Our findings suggest alternative medical treatment methods based on gene-gene interactions, gene-microRNA (miRNA) interactions, gene-drug interactions, and pharmacogenetic variants involved in dementia and psychiatric disorders. We identify 17 genes commonly associated with both dementia and delirium including apolipoprotein E (ApoE), brain-derived neurotrophic factor (BDNF), catechol-O-methyltransferase (COMT), butyrylcholinesterase (BChE), acetylcholinesterase (AChE), DNA methyltransferase 1 (DNMT1), prion protein (PrP), tumor necrosis factor (TNF), serine palmitoyltransferase long chain base subunit 1 (SPTLC1), microtubule-associated protein tau (MAPT), alpha-synuclein (αS), superoxide dismutase 1 (SOD1), amyloid beta precursor protein (APP), neurofilament light (NFL), neurofilament heavy, 5-hydroxytryptamine receptor 2A (HTR2A), and serpin family A member 3 (ERAP3). In addition, we identify six main genes that form an inner concentric model, as well as their associated miRNA. The FDA-approved medications that were found to be effective against the six main genes were identified. Furthermore, the PharmGKB database was used to identify variants of these six genes in order to suggest future treatment options. We also looked at previous research and evidence on biomarkers that could be used to detect DSD. According to research, there are three types of biomarkers that can be used depending on the stage of delirium. The pathological mechanisms underlying delirium are also discussed. This review will identify treatment and diagnostic options for personalized DSD management. |
format | Online Article Text |
id | pubmed-10163832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-101638322023-05-07 A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management Jahangir, Saira Allala, Manoj Khan, Armughan S Muyolema Arce, Veronica E Patel, Anandkumar Soni, Karsh Sharafshah, Alireza Cureus Neurology Delirium superimposed on dementia (DSD) occurs when patients with pre-existing dementia develop delirium. This complication causes patients to become impaired, posing safety concerns for both hospital staff and patients. Furthermore, there is an increased risk of worsening functional disability and death. Despite medical advances, DSD provides both diagnostic and therapeutic challenges to providers. Identifying at-risk patients and providing personalized medicine and patient care can decrease disease burden in a time-efficient manner. This review delves into bioinformatics-based studies of DSD in order to design and implement a personalized medicine-based approach. Our findings suggest alternative medical treatment methods based on gene-gene interactions, gene-microRNA (miRNA) interactions, gene-drug interactions, and pharmacogenetic variants involved in dementia and psychiatric disorders. We identify 17 genes commonly associated with both dementia and delirium including apolipoprotein E (ApoE), brain-derived neurotrophic factor (BDNF), catechol-O-methyltransferase (COMT), butyrylcholinesterase (BChE), acetylcholinesterase (AChE), DNA methyltransferase 1 (DNMT1), prion protein (PrP), tumor necrosis factor (TNF), serine palmitoyltransferase long chain base subunit 1 (SPTLC1), microtubule-associated protein tau (MAPT), alpha-synuclein (αS), superoxide dismutase 1 (SOD1), amyloid beta precursor protein (APP), neurofilament light (NFL), neurofilament heavy, 5-hydroxytryptamine receptor 2A (HTR2A), and serpin family A member 3 (ERAP3). In addition, we identify six main genes that form an inner concentric model, as well as their associated miRNA. The FDA-approved medications that were found to be effective against the six main genes were identified. Furthermore, the PharmGKB database was used to identify variants of these six genes in order to suggest future treatment options. We also looked at previous research and evidence on biomarkers that could be used to detect DSD. According to research, there are three types of biomarkers that can be used depending on the stage of delirium. The pathological mechanisms underlying delirium are also discussed. This review will identify treatment and diagnostic options for personalized DSD management. Cureus 2023-05-06 /pmc/articles/PMC10163832/ /pubmed/37159618 http://dx.doi.org/10.7759/cureus.38627 Text en Copyright © 2023, Jahangir et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Jahangir, Saira Allala, Manoj Khan, Armughan S Muyolema Arce, Veronica E Patel, Anandkumar Soni, Karsh Sharafshah, Alireza A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management |
title | A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management |
title_full | A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management |
title_fullStr | A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management |
title_full_unstemmed | A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management |
title_short | A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management |
title_sort | review of biomarkers in delirium superimposed on dementia (dsd) and their clinical application to personalized treatment and management |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163832/ https://www.ncbi.nlm.nih.gov/pubmed/37159618 http://dx.doi.org/10.7759/cureus.38627 |
work_keys_str_mv | AT jahangirsaira areviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT allalamanoj areviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT khanarmughans areviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT muyolemaarceveronicae areviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT patelanandkumar areviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT sonikarsh areviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT sharafshahalireza areviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT jahangirsaira reviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT allalamanoj reviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT khanarmughans reviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT muyolemaarceveronicae reviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT patelanandkumar reviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT sonikarsh reviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement AT sharafshahalireza reviewofbiomarkersindeliriumsuperimposedondementiadsdandtheirclinicalapplicationtopersonalizedtreatmentandmanagement |